{"id":186593,"date":"2015-02-26T03:53:51","date_gmt":"2015-02-26T08:53:51","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/qiagen-collaborates-with-allele-frequency-community-to-advance-translational-medicine-and-clinical-diagnostics.php"},"modified":"2015-02-26T03:53:51","modified_gmt":"2015-02-26T08:53:51","slug":"qiagen-collaborates-with-allele-frequency-community-to-advance-translational-medicine-and-clinical-diagnostics","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/qiagen-collaborates-with-allele-frequency-community-to-advance-translational-medicine-and-clinical-diagnostics.php","title":{"rendered":"QIAGEN Collaborates With Allele Frequency Community To Advance Translational Medicine And Clinical Diagnostics"},"content":{"rendered":"<p><p>    Allele Frequency Community formed to significantly address    need to improve the interpretation of DNA findings on    disease-causing gene variants and rare diseases  <\/p>\n<p>    A coalition of 13 leading life science and diagnostics    organizations recently announced the formation of the Allele    Frequency Community, a landmark initiative that is creating an    extensive, high-quality and ethnically diverse collection of    human genomes to address a key challenge in interpreting    sequencing data for research and clinical applications. The    announcement coincides with the start of the 16th annual    Advances in Genome Biology and Technology (AGBT) scientific    meeting in Marco Island, Florida.  <\/p>\n<p>    The Allele Frequency Community was recently formed after the 13    organizations agreed to pool their extensive human exome- and    genome-wide variant call datasets in a secure, anonymized,    pooled fashion to create the most ethnically diverse,    freely-accessible, hosted community database of allele    frequencies available. Until now, labs often collected their    own, private allele frequency libraries, but did not have the    infrastructure and incentives to integrate their resources into    a freely-available community asset.  <\/p>\n<p>    Increasing participation in this community-based resource is    expected to create greater value over time. In particular, the    Allele Frequency Community has the potential to create    increasing value for life sciences and clinical research since    information on observed allele frequencies can create important    benchmarks that significantly increase the accuracy of findings    from data generated by molecular analyses, such as    Next-Generation Sequencing (NGS).  <\/p>\n<p>    To enable this resource to grow, users have the opportunity to    opt-in to join the Allele Frequency Community and benefit from    the extensive database, agreeing in return to contribute    statistics from their sequences to the database. Only    anonymous, pooled allele frequencies are provided, protecting    patient privacy.  <\/p>\n<p>    The Allele Frequency Community database already holds more than    70,000 variant call datasets including 8,000 whole genomes and    has been shown in internal benchmarking studies to generate a    43% average reduction in false positive rates in causal variant    identification.  <\/p>\n<p>    The founding collaborators of the Allele Frequency Community    are:  <\/p>\n<p>    QIAGEN N.V. is one of the founding collaborators of the Allele    Frequency Community, and is providing bioinformatics    infrastructure and software for the development of this    community-based resource.  <\/p>\n<p>    Over the last few years, access to allele frequency data from    large populations has been the most useful resource for the    interpretation of human variation, said Dr. Heidi Rehm, Ph.D.,    Director of the Laboratory for Molecular Medicine at Partners    Healthcare Personalized Medicine. The Allele Frequency    Community is a really valuable project. I am happy to share    data through this new resource and excited that many other    people have agreed to do so as well.  <\/p>\n<p>    An allele is an alternative form of a gene found in a persons    DNA. Scientists need diverse, large-scale data on allele    frequencies to accurately identify potential disease-causing    DNA changes in a population. Information on allele frequency    also tells clinicians how common certain changes are within the    population, helping to distinguish rare, disease-causing DNA    changes from more common variations. A key challenge has been    the lack of extensive collections of human genomes as a    reference set. A prospective disease-causing variant that    appears to be rare based on publicly available data may in    fact be more prevalent in an ethnic population    under-represented in public databases.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.bioprocessonline.com\/doc\/qiagen-collaborates-with-allele-frequency-community-to-advance-0001?atc~c=771+s=773+r=001+l=a\/RK=0\/RS=VFC80fNI30lTf6MtPOJmbEo2bPo-\" title=\"QIAGEN Collaborates With Allele Frequency Community To Advance Translational Medicine And Clinical Diagnostics\">QIAGEN Collaborates With Allele Frequency Community To Advance Translational Medicine And Clinical Diagnostics<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Allele Frequency Community formed to significantly address need to improve the interpretation of DNA findings on disease-causing gene variants and rare diseases A coalition of 13 leading life science and diagnostics organizations recently announced the formation of the Allele Frequency Community, a landmark initiative that is creating an extensive, high-quality and ethnically diverse collection of human genomes to address a key challenge in interpreting sequencing data for research and clinical applications.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/qiagen-collaborates-with-allele-frequency-community-to-advance-translational-medicine-and-clinical-diagnostics.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-186593","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/186593"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=186593"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/186593\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=186593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=186593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=186593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}